The pen and the scalpel: Effect of diffusion of information on nonclinical variations in surgical treatment

Medical Care

Volumn 47, Issue 7, 2009, Pages 749-757

  Griggs, Jennifer J ^a   Sorbero, Melony E S ^b   Ahrendt, Gretchen M ^c   Stark, Azadeh ^d   Heininger, Susanne ^e   Gold, Heather T ^f   Schiffhauer, Linda M ^e   Dick, Andrew W ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Diffusion; Ductal carcinoma in situ; Insurance; Variation

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCTAL CARCINOMA IN SITU; CARCINOMA IN SITU; CLINICAL PRACTICE; CONSENSUS; FEMALE; HEALTH INSURANCE; HUMAN; INFORMATION DISSEMINATION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; TIME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIFFUSION OF INNOVATION; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HUMANS; INFORMATION DISSEMINATION; LOGISTIC MODELS; LYMPH NODE EXCISION; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; REIMBURSEMENT MECHANISMS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 67649797465     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31819748b3     Document Type: Article

References (45)

1. Eddy DM. Variations in physician practice: the role of uncertainty. Health Aff (Millwood). 1984;3:74-89.
2. Phelps CE. Diffusion of information in medical care. J Econ Perspect. 1992;6:23-42.
3. Birkmeyer JD, Sharp SM, Finlayson SR, et al. Variation profiles of common surgical procedures. Surgery. 1998;124:917-923.
4. Chassin MR. Explaining geographic variations. The enthusiasm hypothesis. Med Care. 1993;31:YS37-YS44.
5. Newcomb JL. Persistence of outmoded medical practices (Dissertation). St. Louis: Washington University; 1995.
6. Wennberg JE. Unwarranted variations in healthcare delivery: implications for academic medical centres. BMJ. 2002;325:961-964.
7. Groenewegen PP, Westert GP. Is there a time trend in medical practice variations? A review of the literature and a critical analysis of theoretical approaches. J Public Health. 2004;12:229-236.
8. Hadley J, Mandelblatt JS, Mitchell JM, et al. Medicare breast surgery fees and treatment received by older women with localized breast cancer. Health Serv Res. 2003;38:553-573.
9. Shen J, Andersen R, Brook R, et al. The effects of payment method on clinical decision-making: physician responses to clinical scenarios. Med Care. 2004;42:297-302.
10. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal breast carcinoma-is it indicated? Cancer. 1987;59:1819-1824.
11. Harris JR, Lipman ME, Morrow M, et al. eds. Diseases of the Breast. Philadelphia, PA: Lippincott-Raven Publishers; 1996.
12. Carlson RW, Goldstein LJ, Gradishar WJ, et al. NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996;10:47-75.
13. Andersen R, Aday LA. Access to medical care in the US: realized and potential. Med Care. 1978;16:533-546.
14. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Sco Behav. 1995;36:1-10.
15. Yen TW, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005;200:516-526.
16. Zelis JJ, Sickle-Santanello BJ, Liang WC, et al. Do not contemplate invasive surgery for ductal carcinoma in situ. Am J Surg. 2002;184:348-349.
17. Goyal A, Douglas-Jones A, Monypenny I, et al. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Cancer Res Treat. 2006;98:311-314.
18. Veronesi P, Intra M, Vento AR, et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast. 2005;14:520-522.
19. Tan JC, McCready DR, Easson AM, et al. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Ann Surg Oncol. 2007;14:638-645.
20. Bland KI, Scott-Conner CE, Menck H, et al. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg. 1999; 188:586-595, discussion 595-586.
21. Du X, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer. Breast Cancer Res Treat. 1999;53:137-144.
22. Truong PT, Bernstein V, Wai E, et al. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. 2002;54:794-803.
23. Edge SB, Gold K, Berg CD, et al. Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer. 2002;94:2534-2541.
24. Enger SM, Thwin SS, Buist DS, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24:4377-4383.
25. Hillner BE, Penberthy L, Desch CE, et al. Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat. 1996;40:75-86.
26. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
27. Garber AM, MaCurdy TE. Nursing home discharges and exhaustion of Medicare benefits. J Am Stat Assoc. 1993;88:727-736.
28. Baxter NN, Virnig BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96:443-448.
29. Porembka MR, Abraham RL, Sefko JA, et al. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 SEER data. Ann Surg Oncol. 2008;15:2709-2719.
30. Schwartz GF, Solin LJ, Olivotto IA, et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast, 22-25 April 1999. Breast. 2000;9:177-186.
31. Mandelblatt JS, Berg CD, Meropol NJ, et al. Measuring and predicting surgeons' practice styles for breast cancer treatment in older women. Med Care. 2001;39:228-242.
32. Unger JM, Coltman CA Jr, Crowley JJ, et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol. 2006;24:141-144.
33. Ware JE Jr, Brook R, Davies-Avery A, et al. Conceptualization and measurement of health for adults in health insurance study: Vol. 1, model of health and methodology. In: Corporation R, ed. Model for Health and Methodology. Santa Monica, CA: RAND Corporation; 1980.
34. Schulze T, Mucke J, Markwardt J, et al. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol. 2006;93:109-119.
35. Mandelblatt JS, Edge SB, Meropol NJ, et al. Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. Cancer. 2002;95:2445-2454.
36. Perrier L, Nessah K, Morelle M, et al. Cost comparison of two surgical strategies in the treatment of breast cancer: Sentinel lymph node biopsy versus axillary lymph node dissection. Int J Technol Assess Health Care. 2004;20:449-454.
37. Ronka R, Smitten K, Sintonen H, et al. The impact of sentinel node biopsy and axillary staging strategy on hospital costs. Ann Oncol. 2004;15:88-94.
38. Chirikos TN, Berman CG, Luther SL, et al. Cost consequences of sentinel lymph node biopsy in the treatment of breast cancer. A preliminary analysis. Int J Technol Assess Health Care. 2001;17:626-631.
39. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol. 2001; 8:275-277.
40. Lara JF, Young SM, Velilla RE, et al. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: A clinicopathologic study with long-term follow-up. Cancer. 2003;98:2105-2113.
41. Sakr R, Barranger E, Antoine M, et al. Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol. 2006;94:426-430.
42. Mabry H, Giuliano AE, Silverstein MJ. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Am J Surg. 2006;192:455-457.
43. van Deurzen CH, Hobbelink MG, van Hillegersberg R, et al. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer. 2007;43:993-1001.
44. Edge SB. Early adoption and disturbing disparities in sentinel node biopsy in breast cancer. J Natl Cancer Inst. 2008;100:449-450.
45. Chen AY, Halpern MT, Schrag NM, et al. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). J Natl Cancer Inst. 2008;100:462-474.